Our global Injectables business is delivering a solid revenue performance, driven by each of our three geographies ...

Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ETCompany ParticipantsBill Szablewski - Head of Capital MarketsScott Smith ...

In North America we are benefitting from good demand for the recently launched liraglutide injection ... global supply chain for our raw and packaging materials, including active pharmaceutical ...

As demand for GLP-1 medications surges, Hydreight’s inclusion of Liraglutide introduces a stable, patent-free, and clinically proven option—ideal for patients and providers seeking consistent ...

Researchers at Virginia Tech have found a way to make biodegradable packaging stronger while using less energy in the process. The research team from the College of Agriculture and Life Sciences ...

is pleased to announce the expansion of its VSDHOne platform with the launch of Liraglutide. This addition marks a strategic expansion of Hydreight’s growing GLP-1 weight management and wellness ...